awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33411277-388A58DF-63FA-4730-A72C-91860708FE68
Q33411277-388A58DF-63FA-4730-A72C-91860708FE68
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33411277-388A58DF-63FA-4730-A72C-91860708FE68
Phase 2 trial of intravenously administered plerixafor for stem cell mobilization in patients with multiple myeloma following lenalidomide-based initial therapy.
P2860
Q33411277-388A58DF-63FA-4730-A72C-91860708FE68
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33411277-388A58DF-63FA-4730-A72C-91860708FE68
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
105b20e14cf52ddb99090c20589b45dd52c9e972
P2860
International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100).